Advertisement

Inpharma Weekly

, Volume 1247, Issue 1, pp 7–7 | Cite as

IFN-β cost effective for MS after all?

Review
  • 4 Downloads

Keywords

Multiple Sclerosis Standard Care Annual Cost Societal Perspective Disability Progression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2000

Personalised recommendations